Potential role of human challenge studies for investigation of influenza transmission

The Lancet Infectious Diseases

Volumn 11, Issue 11, 2011, Pages 879-886

  Killingley, Ben ^a   Enstone, Joanne ^a   Booy, Robert ^b   Hayward, Andrew ^c   Oxford, John ^d   Ferguson, Neil ^e   van Tam, Jonathan Nguyen ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NATIONAL CENTRE FOR IMMUNISATION RESEARCH AND SURVEILLANCE   (Australia)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE;

ANTIVIRAL THERAPY; CROSS INFECTION; HAND WASHING; HUMAN; INFECTION CONTROL; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; NOTE; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; SURGICAL MASK; VIRUS TRANSMISSION;

DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MODELS, BIOLOGICAL; ORTHOMYXOVIRIDAE;

EID: 82455171694     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70142-6     Document Type: Note

References (55)

1. Potter CW A history of influenza. J Appl Microbiol 2001, 91:572-579.
2. Smith W, Andrewes CH, Laidlaw PP A virus obtained from influenza patients. Lancet 1933, 222:66-68.
3. Tellier R Review of aerosol transmission of influenza A virus. Emerg Infect Dis 2006, 12:1657-1662.
4. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M Transmission of influenza A in human beings. Lancet Infect Dis 2007, 7:257-265.
5. Pandemic (H1N1) influenza: a summary of guidance for infection control in healthcare settings Department of Health - England, (accessed March 8, 2011). http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_110902.
6. National plan for the prevention and control "Influenza pandemic" Secrétariat general de la défense nationale, (accessed March 8, 2011). http://www.pandemie-grippale.gouv.fr/IMG/pdf/plan_PG_2009_en.pdf.
7. Interim guidance on infection control measures for 2009 H1N1 influenza in healthcare settings, including protection of healthcare personnel CDC, (accessed March 9, 2011). http://www.cdc.gov/h1n1flu/guidelines_infection_control.htm.
8. Preparing for an influenza pandemic: personal protective equipment for healthcare workers 2007, Institute of Medicine of the National Academies, National Academies Press, Washington, DC.
9. Influenza transmission: research needs for informing infection control policies and practice Influenza Team (ECDC), (accessed May 27, 2011). http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=3189.
10. WHO public health research agenda for influenza WHO, (accessed May 27, 2011). http://www.who.int/csr/disease/influenza/research_agenda/en/.
11. Tellier R Aerosol transmission of influenza A virus: a review of new studies. J R Soc Interface 2009, 6(suppl 6):S783-S790.
12. Bridges CB, Kuehnert MJ, Hall CB Transmission of influenza: implications for control in health care settings. Clin Infect Dis 2003, 37:1094-1101.
13. Weber TP, Stilianakis NI Inactivation of influenza A viruses in the environment and modes of transmission: a critical review. J Infect 2008, 57:361-373.
14. Belser JA, Maines TR, Tumpey TM, Katz JM Influenza A virus transmission: contributing factors and clinical implications. Expert Rev Mol Med 2010, 12:e39.
15. Rosenau MJ Experiments to determine the mode of spread of influenza. JAMA 1919, 73:311-313.
16. Tyrell D, Fielder M Cold wars: fight against the common cold 2002, Oxford University Press, Oxford.
17. Tyrrell DA A view from the common cold unit. Antiviral Res 1992, 18:105-125.
18. Hall CB, Douglas RG Modes of transmission of respiratory syncytial virus. J Pediatr 1981, 99:100-103.
19. Gwaltney JM, Moskalski PB, Hendley JO Hand-to-hand transmission of rhinovirus colds. Ann Intern Med 1978, 88:463-467.
20. Meschievitz CK, Schultz SB, Dick EC A model for obtaining predictable natural transmission of rhinoviruses in human volunteers. J Infect Dis 1984, 150:195-201.
21. Dick EC, Jennings LC, Mink KA, Wartgow CD, Inhorn SL Aerosol transmission of rhinovirus colds. J Infect Dis 1987, 156:442-448.
22. Hendley JO, Gwaltney JM Mechanisms of transmission of rhinovirus infections. Epidemiol Rev 1988, 10:243-258.
23. Couch RB, Cate TR, Douglas RG, Gerone PJ, Knight V Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission. Bacteriol Rev 1966, 30:517-529.
24. Smorodintseff AA, Tushinsky MD, Drobyshevskaya AI, Korovin AA, Osetroff AI Investigation on volunteers infected with the influenza virus. Am J Med Sci 1937, 194:159-170.
25. Henle W, Henle G, Stokes J, Maris EP Experimental exposure of human subjects to viruses of influenza. J Immunol 1946, 52:145-165.
26. Alford RH, Kasel JA, Gerone PJ, Knight V Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol Med 1966, 122:800-804.
27. Couch RB, Douglas RG, Fedson DS, Kasel JA Correlated studies of a recombinant influenza-virus vaccine: 3-protection against experimental influenza in man. J Infect Dis 1971, 124:473-480.
28. Douglas R Influenza in man. Influenza viruses and influenza 1975, 395-418. Academic Press, New York. E. Kilbourne (Ed.).
29. Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA 1996, 275:295-299.
30. Little JW, Douglas RG, Hall WJ, Roth FK Attenuated influenza produced by experimental intranasal inoculation. J Med Virol 1979, 3:177-188.
31. Kaiser L, Henry D, Flack NP, Keene O, Hayden FG Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study. Clin Infect Dis 2000, 30:587-589.
32. Tannock GA, Gillett SM, Gillett RS, et al. A study of intranasally administered interferon A (rIFN-alpha 2A) for the seasonal prophylaxis of natural viral infections of the upper respiratory tract in healthy volunteers. Epidemiol Infect 1988, 101:611-621.
33. Monto AS, Pichichero ME, Blanckenberg SJ, et al. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. J Infect Dis 2002, 186:1582-1588.
34. Monto AS, Robinson DP, Herlocher ML, Hinson JM, Elliott MJ, Crisp A Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA 1999, 282:31-35.
35. Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008, 167:775-785.
36. Microbial challenge studies of human volunteers The Academy of Medical Sciences, (accessed May 27, 2011). http://www.acmedsci.ac.uk/download.php?file=/images/publication/1127728424.pdf.
37. Ison MG, Campbell V, Rembold C, Dent J, Hayden FG Cardiac findings during uncomplicated acute influenza in ambulatory adults. Clin Infect Dis 2005, 40:415-422.
38. Bell DM Non-pharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis 2006, 12:88-94.
39. Talaat M, Afifi S, Dueger E, et al. Effects of hand hygiene campaigns on incidence of laboratory-confirmed influenza and absenteeism in schoolchildren, Cairo, Egypt. Emerg Infect Dis 2011, 17:619-625.
40. Aiello AE, Murray GF, Perez V, et al. Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. J Infect Dis 2010, 201:491-498.
41. Cowling BJ, Chan KH, Fang VJ, et al. Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med 2009, 151:437-446.
42. MacIntyre CR, Cauchemez S, Dwyer DE, et al. Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis 2009, 15:233-241.
43. Larson EL, Ferng YH, Wong-McLoughlin J, Wang S, Haber M, Morse SS Impact of non-pharmaceutical interventions on URIs and influenza in crowded, urban households. Public Health Rep 2010, 125:178-191.
44. Simmerman JM, Suntarattiwong P, Levy J, et al. Findings from a household randomized controlled trial of hand washing and face masks to reduce influenza transmission in Bangkok, Thailand. Influenza Other Respi Viruses 2011, 5:256-267.
45. Loeb M, Dafoe N, Mahony J, et al. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA 2009, 302:1865-1871.
46. MacIntyre CR, Wang Q, Cauchemez S, et al. A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers. Influenza Other Respi Viruses 2011, 5:170-179.
47. Stebbins S, Cummings DA, Stark JH, et al. Reduction in the incidence of influenza A but not influenza B associated with use of hand sanitizer and cough hygiene in schools: a randomized controlled trial. Pediatr Infect Dis J (published online June 17, 2011). DOI:10.1097/INF.0b013e3182218656.
48. McLean E, Murdoch H, Reynolds A, et al. Surveillance of influenza and other respiratory viruses in the United Kingdom: October 2008 to April 2009. Health Protection Report weekly report, vol 3 no 39 (Oct 2, 2009) 2009, 7-24. Health Protection Agency, London.
49. United States surveillance data: 1997-1998 through 2007-2008 seasons CDC, (accessed March 9, 2011). http://www.cdc.gov/flu/weekly/ussurvdata.htm.
50. Goldmann DA Transmission of viral respiratory infections in the home. Pediatr Infect Dis J 2000, 19(10 suppl):S97-102.
51. Carrat F, Sahler C, Rogez S, et al. Influenza burden of illness: estimates from a national prospective survey of household contacts in France. Arch Intern Med 2002, 162:1842-1848.
52. Lau LL, Cowling BJ, Fang VJ, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis 2010, 201:1509-1516.
53. Lindsley WG, Blachere FM, Thewlis RE, et al. Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS One 2010, 5:e15100.
54. Milton DK, Fabian P, Angel M, Perez DR, McDevitt JJ. Influenza virus aerosols in human exhaled breath: particle size, culturability and effect of surgical masks. Swine origin H1N1 virus: the first pandemic of the 21st century; April 18-20, 2010; Atlanta, GA, USA. Abstract 20 p.
55. Killingley B, Nguyen Van-Tam J, on behalf of the Influenza Transmission Strategy Development Group. Influenza transmission: a challenging subject. Options for the Control of Influenza VII; Sept 3-7, 2010; Hong Kong, China. Abstract ws-6b.